Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Antimalarial use and the associated factors in rural Nigeria following implementation of Affordable Medicines Facility-Malaria (AMFM) price subsidy

Purpose This study was set out to find out the pattern of antimalarial drug use in a Nigerian rural community following the aggressive price subsidy of Artemisinin Combination Therapy(ACT) recently embarked upon by Roll Back Malaria partners through Affordable Medicines Facility-malaria (AMFm). Meth...

Full description

Saved in:
Bibliographic Details
Format: Article
Published: 2013
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000njm a2000000a 4500
001 oai:repository.ui.edu.ng:123456789/12687
042 |a dc 
720 |a Efunshile, A. M.  |e author 
720 |a Fowotade, A.  |e author 
720 |a Makanjuola, O. B.  |e author 
720 |a Oyediran, E. I.  |e author 
720 |a Olusanya, O. O.  |e author 
720 |a Koenig, B.  |e author 
260 |c 2013 
520 |a Purpose This study was set out to find out the pattern of antimalarial drug use in a Nigerian rural community following the aggressive price subsidy of Artemisinin Combination Therapy(ACT) recently embarked upon by Roll Back Malaria partners through Affordable Medicines Facility-malaria (AMFm). Methods Questioners were administered to 310 adult members of the community with the most recent malaria episodes so as to find out about the drugs used and some of the factors associated with the choice of the drug. Result Although the overall use of ACT (13.55%) in this community was about 4 times higher than what it used to be, Chloroquine 123(39.62%) and sulphadozine/pyrimathamine 120(38.71%) were the mostly used antimalarial agents. Choice of drug used was significantly associated with perception of efficacy and price among other factors. Respondents liked the price of ACT (33.3%) most, CQ was the drug most liked in terms of efficacy (44.2%) while SP was the drug most liked in terms of lack of side effect (38.9%), taste (61.6%) and convenience (35.7%).( P= 0.001) Conclusion In addition to sustaining the current price control, there is a need to continuously monitor and effectively regulate the quality of the ACTs in circulation so as to gain the confidence of both the prescribers and the end users regarding efficacy and adherence to ACTs. This will help to safeguard the huge investment in ACT subsidy by the Roll Back Malaria partners. 
024 8 |a 1595-689X 
024 8 |a ui_art_efunshile_antimalarial_2013 
024 8 |a American Journal of Infectious Diseases 14(2), pp. 88-94 
024 8 |a https://repository.ui.edu.ng/handle/123456789/12687 
653 |a ACT 
653 |a Subsidy 
653 |a Affordable 
653 |a Medicines 
653 |a Facility-malaria 
245 0 0 |a Antimalarial use and the associated factors in rural Nigeria following implementation of Affordable Medicines Facility-Malaria (AMFM) price subsidy